Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bontempi

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Medical & Biological Engineering & Computing|May 1, 1990
Spectral analysis of heart rate variability signal and respiration in diabetic subjectsA Bianchi, B Bontempi, S Cerutti, et al.
Molecular Psychiatry|January 7, 2015
Acute tianeptine treatment selectively modulates neuronal activation in the central nucleus of the amygdala and attenuates fear extinctionB P Godsil, B Bontempi, F Mailliet, et al.
Journal of the Autonomic Nervous System|July 1, 1990
Spectral analysis of short-term heart rate variability in diabetic patientsG Comi, M G Sora, A Bianchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primatesB Bontempi, K T Whelan, V B Risbrough, et al.
Journal of Medicinal Chemistry|May 29, 1999
4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptorsJ M Vernier, H El-Abdellaoui, H Holsenback, et al.
Life Sciences|May 19, 1998
The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agentsG K Lloyd, F Menzaghi, B Bontempi, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Medical & Biological Engineering & Computing|May 1, 1990
Spectral analysis of heart rate variability signal and respiration in diabetic subjectsA Bianchi, B Bontempi, S Cerutti, et al.
Molecular Psychiatry|January 7, 2015
Acute tianeptine treatment selectively modulates neuronal activation in the central nucleus of the amygdala and attenuates fear extinctionB P Godsil, B Bontempi, F Mailliet, et al.
Journal of the Autonomic Nervous System|July 1, 1990
Spectral analysis of short-term heart rate variability in diabetic patientsG Comi, M G Sora, A Bianchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primatesB Bontempi, K T Whelan, V B Risbrough, et al.
Journal of Medicinal Chemistry|May 29, 1999
4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptorsJ M Vernier, H El-Abdellaoui, H Holsenback, et al.
Life Sciences|May 19, 1998
The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agentsG K Lloyd, F Menzaghi, B Bontempi, et al.
Pageof 2